SLTX Trademark

Trademark Overview


On Friday, November 16, 2018, a trademark application was filed for SLTX with the United States Patent and Trademark Office. The USPTO has given the SLTX trademark a serial number of 88197578. The federal status of this trademark filing is REGISTERED as of Tuesday, November 17, 2020. This trademark is owned by Sigilon Therapeutics, Inc.. The SLTX trademark is filed in the Chemical Products and Pharmaceutical Products categories with the following description:

Chemical, pharmaceutical, biopharmaceutical and biomedical agents for medical use, namely, pharmaceutical agents for modulating immune response; chemical agents for pharmaceutical or medical purposes, namely, pharmaceutical agents for modulating immune response; pharmaceutical agents for encapsulating transplanted cells to prevent the risk of rejection from immune attack, for medical purposes; pharmaceutical preparations for the prevention and treatment of fibrosis, inflammation, cancer or infection; drug delivery agents in the form of coatings for capsules that facilitate the tolerance and delivery of pharmaceutical preparations; chemical agents, namely, drug delivery agents in the form of coatings that facilitate the delivery of pharmaceutical agents and cells

Chemical agents for coating of medical devices and medical materials; reagents for research purposes; reagents for scientific or medical research use
sltx

General Information


Serial Number88197578
Word MarkSLTX
Filing DateFriday, November 16, 2018
Status700 - REGISTERED
Status DateTuesday, November 17, 2020
Registration Number6201037
Registration DateTuesday, November 17, 2020
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 9, 2019

Trademark Statements


Goods and ServicesChemical, pharmaceutical, biopharmaceutical and biomedical agents for medical use, namely, pharmaceutical agents for modulating immune response; chemical agents for pharmaceutical or medical purposes, namely, pharmaceutical agents for modulating immune response; pharmaceutical agents for encapsulating transplanted cells to prevent the risk of rejection from immune attack, for medical purposes; pharmaceutical preparations for the prevention and treatment of fibrosis, inflammation, cancer or infection; drug delivery agents in the form of coatings for capsules that facilitate the tolerance and delivery of pharmaceutical preparations; chemical agents, namely, drug delivery agents in the form of coatings that facilitate the delivery of pharmaceutical agents and cells
Goods and ServicesChemical agents for coating of medical devices and medical materials; reagents for research purposes; reagents for scientific or medical research use

Classification Information


International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status Code6 - Active
Class Status DateTuesday, December 4, 2018
Primary Code001
First Use Anywhere DateThursday, September 17, 2020
First Use In Commerce DateThursday, September 17, 2020

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, December 4, 2018
Primary Code005
First Use Anywhere DateTuesday, July 28, 2020
First Use In Commerce DateTuesday, July 28, 2020

Trademark Owner History


Party NameSigilon Therapeutics, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02142

Party NameSigilon Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCambridge, MA 02142

Party NameSigilon Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02142

Trademark Events


Event DateEvent Description
Tuesday, November 20, 2018NEW APPLICATION ENTERED
Tuesday, December 4, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, February 20, 2019ASSIGNED TO EXAMINER
Monday, February 25, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, March 20, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, April 9, 2019PUBLISHED FOR OPPOSITION
Tuesday, April 9, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 4, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, November 4, 2019SOU TEAS EXTENSION RECEIVED
Monday, November 4, 2019SOU EXTENSION 1 FILED
Monday, November 4, 2019SOU EXTENSION 1 GRANTED
Wednesday, November 6, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, May 19, 2020SOU TEAS EXTENSION RECEIVED
Tuesday, May 19, 2020SOU EXTENSION 2 FILED
Tuesday, May 19, 2020SOU EXTENSION 2 GRANTED
Thursday, May 21, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, September 23, 2020TEAS STATEMENT OF USE RECEIVED
Wednesday, October 7, 2020CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, September 23, 2020USE AMENDMENT FILED
Wednesday, October 7, 2020STATEMENT OF USE PROCESSING COMPLETE
Tuesday, October 13, 2020ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Wednesday, October 14, 2020NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, November 17, 2020REGISTERED-PRINCIPAL REGISTER
Monday, March 18, 2024TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, March 18, 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, March 18, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, March 18, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, March 18, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, November 17, 2025COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED